Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Aethlon Medical, Inc. (AEMD) had Consolidated Net Income/Loss of $-1.88M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.88M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.93M |
|
$0.04M |
|
$-1.88M |
|
$-1.88M |
|
$-1.88M |
|
$-1.88M |
|
|
Consolidated Net Income/Loss |
$-1.88M |
$-1.88M |
|
$-1.93M |
|
$-2.07M |
|
0.67M |
|
0.67M |
|
$4.08 |
|
$4.08 |
|
| Balance Sheet Financials | |
$5.57M |
|
$0.36M |
|
$0.76M |
|
$6.33M |
|
$1.45M |
|
-- |
|
-- |
|
$1.45M |
|
$4.89M |
|
$4.89M |
|
$4.89M |
|
1.57M |
|
| Cash Flow Statement Financials | |
$-7.00M |
|
$-0.00M |
|
$6.52M |
|
$5.60M |
|
$5.13M |
|
$-0.47M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.56% |
|
-38.56% |
|
-29.75% |
|
-38.56% |
|
$3.11 |
|
$-10.39 |
|
$-10.38 |
|